Patricia L Morris

Array ( [id] => 7574077 [patent_doc_number] => 20110269733 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-11-03 [patent_title] => 'Silent Desensitizers of Neuronal nAChR and Methods of Use Thereof' [patent_app_type] => utility [patent_app_number] => 12/994376 [patent_app_country] => US [patent_app_date] => 2009-05-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 16992 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 17 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0269/20110269733.pdf [firstpage_image] =>[orig_patent_app_number] => 12994376 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9620974 [patent_doc_number] => 08791146 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-07-29 [patent_title] => '2-alkoxy-substituted dicyanopyridines and their use' [patent_app_type] => utility [patent_app_number] => 12/995028 [patent_app_country] => US [patent_app_date] => 2009-05-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 27100 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12995028 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6163334 [patent_doc_number] => 20110160249 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-06-30 [patent_title] => '5-LIPOXYGENASE-ACTIVATING PROTEIN INHIBITOR' [patent_app_type] => utility [patent_app_number] => 12/993319 [patent_app_country] => US [patent_app_date] => 2009-05-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 25 [patent_no_of_words] => 56892 [patent_no_of_claims] => 129 [patent_no_of_ind_claims] => 111 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0160/20110160249.pdf [firstpage_image] =>[orig_patent_app_number] => 12993319 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5490910 [patent_doc_number] => 20090291981 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-11-26 [patent_title] => '5-Lipoxygenase-Activating Protein Inhibitor' [patent_app_type] => utility [patent_app_number] => 12/471106 [patent_app_country] => US [patent_app_date] => 2009-05-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 25 [patent_no_of_words] => 54145 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0291/20090291981.pdf [firstpage_image] =>[orig_patent_app_number] => 12471106 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5458895 [patent_doc_number] => 20090259047 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-10-15 [patent_title] => 'BARIUM SALT OF BENZIMIDAZOLE DERIVATIVE' [patent_app_type] => utility [patent_app_number] => 12/467051 [patent_app_country] => US [patent_app_date] => 2009-05-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 2662 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0259/20090259047.pdf [firstpage_image] =>[orig_patent_app_number] => 12467051 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8257719 [patent_doc_number] => 08207198 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-06-26 [patent_title] => 'Substituted triazole derivatives as oxytocin antagonists' [patent_app_type] => utility [patent_app_number] => 12/466785 [patent_app_country] => US [patent_app_date] => 2009-05-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 42581 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12466785 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6007984 [patent_doc_number] => 20110060015 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-03-10 [patent_title] => '5-[5-[2-(3,5-BIS(Trifluoromethyl)Phenyl)-2-MethylpropanoMethylpropanoylmethylamino]-4-(4-Fluoro-2-Methylphenyl)]-2-Pyridinyl-2-Alkyl-Prolinamide As NK1 Receptor Antagonists' [patent_app_type] => utility [patent_app_number] => 12/991515 [patent_app_country] => US [patent_app_date] => 2009-05-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 22721 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0060/20110060015.pdf [firstpage_image] =>[orig_patent_app_number] => 12991515 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5304234 [patent_doc_number] => 20090298886 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-12-03 [patent_title] => '2-INDOLINONE DERIVATIVES AS MULTI-TARGET PROTEIN KINASE INHIBITORS AND HISTONE DEACETYLASE INHIBITORS' [patent_app_type] => utility [patent_app_number] => 12/463107 [patent_app_country] => US [patent_app_date] => 2009-05-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17073 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0298/20090298886.pdf [firstpage_image] =>[orig_patent_app_number] => 12463107 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5559054 [patent_doc_number] => 20090270631 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-10-29 [patent_title] => 'Therapeutic agent for diabetes' [patent_app_type] => utility [patent_app_number] => 12/453270 [patent_app_country] => US [patent_app_date] => 2009-05-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 162207 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0270/20090270631.pdf [firstpage_image] =>[orig_patent_app_number] => 12453270 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6002977 [patent_doc_number] => 20110118234 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-05-19 [patent_title] => 'Urea Compounds as Gamma Secretase Modulators' [patent_app_type] => utility [patent_app_number] => 12/990999 [patent_app_country] => US [patent_app_date] => 2009-05-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 32187 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0118/20110118234.pdf [firstpage_image] =>[orig_patent_app_number] => 12990999 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5392454 [patent_doc_number] => 20090209767 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-08-20 [patent_title] => '2-(Butyl-1-sulfonylamino)-n-[1(R)-(6-methoxy-pyridin-3-yl)-propyl]-benzamid, the use thereof in the form of drug an pharmaceutical preparations containing said compound' [patent_app_type] => utility [patent_app_number] => 12/432401 [patent_app_country] => US [patent_app_date] => 2009-04-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 4340 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0209/20090209767.pdf [firstpage_image] =>[orig_patent_app_number] => 12432401 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5515717 [patent_doc_number] => 20090216024 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-08-27 [patent_title] => 'Processes for making pioglitazone and compounds of the processes' [patent_app_type] => utility [patent_app_number] => 12/387013 [patent_app_country] => US [patent_app_date] => 2009-04-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4765 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0216/20090216024.pdf [firstpage_image] =>[orig_patent_app_number] => 12387013 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5558830 [patent_doc_number] => 20090270407 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-10-29 [patent_title] => 'FUNGICIDAL ISOXAZOLIDINES' [patent_app_type] => utility [patent_app_number] => 12/428611 [patent_app_country] => US [patent_app_date] => 2009-04-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 34753 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0270/20090270407.pdf [firstpage_image] =>[orig_patent_app_number] => 12428611 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5480707 [patent_doc_number] => 20090203664 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-08-13 [patent_title] => '(1S,5S)-3-(5,6-DICHLORO-3-PYRIDINYL)-3,6- DIAZABICYCLO[3.2.0]HEPTANE' [patent_app_type] => utility [patent_app_number] => 12/426511 [patent_app_country] => US [patent_app_date] => 2009-04-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 22 [patent_no_of_words] => 21192 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0203/20090203664.pdf [firstpage_image] =>[orig_patent_app_number] => 12426511 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5458756 [patent_doc_number] => 20090258908 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-10-15 [patent_title] => 'Crystalline S-Omeprazole Strontium Hydrate, Method For Preparing Same, And Pharmaceutical Composition Containing Same' [patent_app_type] => utility [patent_app_number] => 12/425499 [patent_app_country] => US [patent_app_date] => 2009-04-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 4968 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0258/20090258908.pdf [firstpage_image] =>[orig_patent_app_number] => 12425499 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5978243 [patent_doc_number] => 20110071197 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-03-24 [patent_title] => 'BIS-ARYL COMPOUNDS FOR USE AS MEDICAMENTS' [patent_app_type] => utility [patent_app_number] => 12/937799 [patent_app_country] => US [patent_app_date] => 2009-04-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 60336 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0071/20110071197.pdf [firstpage_image] =>[orig_patent_app_number] => 12937799 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5954831 [patent_doc_number] => 20110034696 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-02-10 [patent_title] => 'PROCESS FOR PRODUCING ANTHRANILAMIDE COMPOUND' [patent_app_type] => utility [patent_app_number] => 12/937647 [patent_app_country] => US [patent_app_date] => 2009-04-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8791 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0034/20110034696.pdf [firstpage_image] =>[orig_patent_app_number] => 12937647 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9355409 [patent_doc_number] => 08673942 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-03-18 [patent_title] => 'Fused ring compounds and use thereof' [patent_app_type] => utility [patent_app_number] => 12/936785 [patent_app_country] => US [patent_app_date] => 2009-04-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 67101 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 8 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12936785 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 152297 [patent_doc_number] => 07678910 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-03-16 [patent_title] => 'Process for producing 5-methyl-4,5,6,7-tetrahydrothiazolo[5,4-c]Pyridine-2-carboxylic acid' [patent_app_type] => utility [patent_app_number] => 12/418750 [patent_app_country] => US [patent_app_date] => 2009-04-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 36222 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/678/07678910.pdf [firstpage_image] =>[orig_patent_app_number] => 12418750 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6361967 [patent_doc_number] => 20100087652 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-04-08 [patent_title] => 'S-Omeprazole Magnesium' [patent_app_type] => utility [patent_app_number] => 12/416537 [patent_app_country] => US [patent_app_date] => 2009-04-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 5422 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0087/20100087652.pdf [firstpage_image] =>[orig_patent_app_number] => 12416537 [rel_patent_id] =>[rel_patent_doc_number] =>)